WebAug 13, 2024 · On July 15, 2024, Dyadic signed a fully funded R&D collaboration with one of the top five global pharmaceutical companies for human health. Under this agreement, Dyadic will be expressing two different types of therapeutic compounds. WebDec 14, 2024 · Press Releases. Mar 7, 2024. Dyadic Provides Phase 1 Clinical Trial Update for its DYAI-100 COVID-19 Recombinant Protein RBD Booster Vaccine Candidate. Mar 1, 2024. Dyadic to Present at Roth Investor Conference and Upcoming Industry Events. Feb 2, …
Dyadic Reports Third Quarter 2024 Financial Results
WebAug 11, 2024 · SAN DIEGO, Aug. 11, 2024 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; “Sorrento”), a clinical stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, and Dyadic International, Inc. (NASDAQ: DYAI; “Dyadic”), a global biotechnology company focused … WebNov 10, 2024 · JUPITER, Fla., Nov. 10, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on building... florence county auto taxes online
Dyadic International To Present At The 2014 Global Biotechnology …
WebMar 15, 2024 · An archive of the webcast will be available within 24 hours after completion of the live event and will be accessible on the Investor Relations section of the Company's website at www.dyadic.com ... WebMar 27, 2024 · JUPITER, FL / ACCESSWIRE / July 29, 2024 / Dyadic International, Inc. ('Dyadic', 'we', 'us', 'our', or the 'Company') (NASDAQ:DYAI), a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate development, lower production costs and improve the … WebAug 10, 2024 · Dyadic International, Inc. is a global biotechnology company committed to building disruptive microbial platforms to address the growing demand for global protein … florence cook and katie king